Search
for
Sort by
Research 31–60 of 262
- Hair Loss Induced by Lopinavir-Ritonavir
- Transmasculine Hormone Therapy
- Dermatologic therapy: December 1987 to December 1988
- Alopecia Associated With Zidovudine Therapy
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- Cross-sex hormone therapy for gender dysphoria
- LncRNA-miRNA-mRNA regulatory networks in skin aging and therapeutic potentials
- Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C
- Alopecia After Switch to Tenofovir Alafenamide in 6 African American Women
- Emerging medication for the treatment of male hypogonadism
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Raltegravir-Induced Alopecia in an HIV+ Patient
- General Dermatology
- Delayed Puberty
- Cutaneous manifestations of endocrine-metabolic disease and nutritional deficiency in the elderly
- Development and Evaluation of a Niosome-Integrated Microneedle System for Targeted Follicular Delivery of Ketoconazole in Alopecia Therapy
- The Role of Hormonal Imbalances in Amenorrhea
- Hair Changes due to Drugs
- Postmenopausal Alopecia (Hair Loss)
- ESGCT and FSGT Collaborative Congress Helsinki, Finland September 17–20, 2015 Abstracts
- Clinical and immunological characteristics of 56 patients with systemic lupus erythematosus in Uganda
- Drug-Induced Hair Disorders
- The Efficacy of Spiritual Healing
- Ethical Principles for Everyone
- Therapeutic effects of stem cells in different body systems, a novel method that is yet to gain trust: A comprehensive review
- Advances in Stem Cell Therapy: Specific Applications in the Treatment of Cutaneous Radiation Syndrome
- Phytosome Based Drug Delivery of Naringenin and Naringin: Development, Characterization, and In Vivo Evaluation
- Postpartum depression: Prevention and multimodal therapy
- Stem Cells Applications in Regenerative Medicine and Disease Therapeutics
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?